Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 65001 - 65025 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	ELAVL1	1994	upregulated	resveratrol results in increased expression of ELAVL1 mRNA	19p13.2	A23930
Resveratrol	Investigational	EN1	2019	downregulated	resveratrol results in decreased expression of EN1 mRNA	2q14.2	A23876
Resveratrol	Investigational	ENC1	8507	downregulated	resveratrol results in decreased expression of ENC1 mRNA	5q13.3	A22498
Resveratrol	Investigational	ENC1	8507	upregulated	resveratrol results in increased expression of ENC1 mRNA	5q13.3	A23847
Resveratrol	Investigational	ENO1	2023	downregulated	resveratrol results in decreased expression of ENO1 mRNA	1p36.23	A23855
Resveratrol	Investigational	ENO2	2026	downregulated	resveratrol results in decreased expression of ENO2 mRNA	12p13.31	A23855
Resveratrol	Investigational	ENO3	2027	downregulated	resveratrol results in decreased expression of ENO3 mRNA	17p13.2	A23855
Resveratrol	Investigational	EP300	2033	downregulated	resveratrol results in decreased expression of EP300 mRNA	22q13.2	A23850
Resveratrol	Investigational	EP300	2033	upregulated	resveratrol results in increased expression of EP300 mRNA	22q13.2	A22498 A23847
Resveratrol	Investigational	EPHA1	2041	upregulated	resveratrol results in increased expression of EPHA1 mRNA	7q34-q35	A20482
Resveratrol	Investigational	EPHA4	2043	upregulated	resveratrol results in increased expression of EPHA4 mRNA	2q36.1	A23847
Resveratrol	Investigational	EPHX1	2052	upregulated	resveratrol results in increased expression of EPHX1 mRNA	1q42.12	A23921 A23858
Resveratrol	Investigational	EPHX2	2053	upregulated	resveratrol results in increased expression of EPHX2 mRNA	8p21.2-p21.1	A23845
Resveratrol	Investigational	EPS15	2060	upregulated	resveratrol results in increased expression of EPS15 mRNA	1p32.3	A22498
Resveratrol	Investigational	ERBB2	2064	downregulated	resveratrol results in decreased expression of ERBB2 mRNA	17q12	A23931
Resveratrol	Investigational	ERBB2	2064	upregulated	resveratrol results in increased expression of ERBB2 mRNA	17q12	A23932
Resveratrol	Investigational	ERBB3	2065	downregulated	resveratrol results in decreased expression of ERBB3 mRNA	12q13.2	A22289
Resveratrol	Investigational	ERCC1	2067	upregulated	resveratrol results in increased stability of and results in increased expression of ERCC1 mRNA	19q13.32	A23584
Resveratrol	Investigational	ERCC3	2071	upregulated	resveratrol results in increased expression of ERCC3 mRNA	2q14.3	A22289
Resveratrol	Investigational	ERRFI1	54206	downregulated	resveratrol results in decreased expression of ERRFI1 mRNA	1p36.23	A21103
Resveratrol	Investigational	ESPN	83715	upregulated	resveratrol results in increased expression of ESPN mRNA	1p36.31	A22289
Resveratrol	Investigational	ESR1	2099	downregulated	resveratrol analog results in decreased expression of ESR1 mRNA	6q25.1-q25.2	A20265
Resveratrol	Investigational	ESR1	2099	downregulated	resveratrol results in decreased expression of ESR1 mRNA	6q25.1-q25.2	A21342 A21265 A23933 A23845 A20265
Resveratrol	Investigational	ESR1	2099	upregulated	resveratrol results in increased expression of ESR1 mRNA	6q25.1-q25.2	A23885 A20491
Resveratrol	Investigational	ESR2	2100	upregulated	resveratrol analog results in increased expression of ESR2 mRNA	14q23.2-q23.3	A20265

Displaying entries 65001 - 65025 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability